Insiders · RACA

RACA insider transactions

Therapeutics Acquisition Corp. (RACA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RACA

• 1752d
  SEC Form 4 filed by Lubner David Charles

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by Malik Rajesh

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by MARGOLIN YAEL

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by GOTTLIEB MICHAEL M.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by HOGUE GERALD L.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by FLESHNER NEIL E.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by DEMERS WILLIAM L.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by GILMOUR MARGARET E.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by JENSEN JESSICA D.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1752d
  SEC Form 4 filed by GOODMAN JONATHAN R.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4: GOTTLIEB MICHAEL M. was granted 1,156,887 units of Common Stock

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4 filed by HOGUE GERALD L.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4 filed by JENSEN JESSICA D.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4: MCCANN JOE A. was granted 3,614,153 units of Common Stock

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4: SILBER ALLAN C was granted 8,864,091 units of Common Stock

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4 filed by DEMERS WILLIAM L.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4: FLESHNER NEIL E. was granted 3,820,778 units of Common Stock

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4 filed by Therapeutics Acquisition Corp.

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4: GOODMAN JONATHAN R. was granted 57,395 units of Common Stock

  4 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by JENSEN JESSICA D.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by Malik Rajesh

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by MARGOLIN YAEL

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by MCCANN JOE A.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by SILBER ALLAN C

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by GOTTLIEB MICHAEL M.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by HOGUE GERALD L.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by Therapeutics Acquisition Corp.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by GILMOUR MARGARET E.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by FLESHNER NEIL E.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 3 filed by DEMERS WILLIAM L.

  3 - POINT Biopharma Global Inc. (0001811764) (Issuer)
• 1760d
  SEC Form 4: RA CAPITAL MANAGEMENT, L.P. bought $2,091,000 worth of Common Stock (209,100 units at $10.00)

  4 - Therapeutics Acquisition Corp. (0001811764) (Issuer)
• 1760d
  SEC Form 4: Kolchinsky Peter was granted 209,100 units of Common Stock

  4 - Therapeutics Acquisition Corp. (0001811764) (Issuer)
• 1766d
  SEC Form 4: Kolchinsky Peter was granted 889,218 units of Common Stock

  4 - Therapeutics Acquisition Corp. (0001811764) (Issuer)
• 1766d
  SEC Form 3: RA CAPITAL MANAGEMENT, L.P. claimed ownership of 889,218 units of Common Stock

  3 - Therapeutics Acquisition Corp. (0001811764) (Issuer)